Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial

Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains

(2020) Kathryn A. Matthias et al.   VACCINE

Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants

(2020) Marta Valente Pinto et al.   Open Forum Infectious Diseases

Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis

(2019) Amaka M. Awanye et al.   Scientific Reports

Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine

(2019) Henju Marjuki et al.   mBio

The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae

(2018) Evgeny A Semchenko et al.   CLINICAL INFECTIOUS DISEASES

A meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and overexpressed Factor H binding protein elicits gonococcal bactericidal antibodies

(2018) Peter T Beernink et al.   JOURNAL OF INFECTIOUS DISEASES

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study

(2017) Helen Petousis-Harris et al.   LANCET

A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C

(2017) Yordanka Masforrol et al.   Human Vaccines & Immunotherapeutics

A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial

(2015) L. Marsay et al.   JOURNAL OF INFECTION

Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines

(2015) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression

(2015) Holly Sanders et al.   PLoS One

Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adults

(2015) Terry Nolan et al.   VACCINE

An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity

(2015) Gunnstein Norheim et al.   PLoS One

The capsular group B meningococcal vaccine, 4CMenB: clinical experience and potential efficacy

(2014) Christine S Rollier et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

The Magnitude of the Antibody and Memory B Cell Responses during Priming with a Protein-Polysaccharide Conjugate Vaccine in Human Infants Is Associated with the Persistence of Antibody and the Intensity of Booster Response

(2014) G. B. Rohner et al.   JOURNAL OF IMMUNOLOGY

Evaluation of the Induction of Immune Memory following Infant Immunisation with Serogroup C Neisseria meningitidis Conjugate Vaccines – Exploratory Analyses within a Randomised Controlled Trial

(2014) Ameneh Khatami et al.   PLoS One

Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot

(2014) Johannes Trück et al.   Human Vaccines & Immunotherapeutics

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose

(2013) M. D. Snape et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Use of a Molecular Decoy to Segregate Transport from Antigenicity in the FrpB Iron Transporter from Neisseria meningitidis

(2013) Muhammad Saleem et al.   PLoS One

The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age

(2013) Geraldine Blanchard-Rohner et al.   VACCINE

Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future

(2013) Johan Holst et al.   Human Vaccines & Immunotherapeutics

The Iron-Repressed, AraC-Like Regulator MpeR Activates Expression offetAin Neisseria gonorrhoeae

(2011) Aimee Hollander et al.   INFECTION AND IMMUNITY

Human antibody and memory B and T-cell responses after primary and booster immunisation against Neisseria meningitidis B

(2011) Simone C. Cruz et al.   VACCINE

The changing and dynamic epidemiology of meningococcal disease

(2011) Scott A. Halperin et al.   VACCINE

Meningococcal carriage and disease—Population biology and evolution

(2009) Dominique A. Caugant et al.   VACCINE

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

(2009) Johan Holst et al.   VACCINE